Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone plus /- Rituximab ( CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)

被引：0
|
作者：
Kouroukis, Tom [1 ]
Cheung, Winson Y. [2 ]
Abdel-Samad, Nizar [3 ]
Sehdev, Sandeep [4 ]
Poulin-Costello, Melanie [5 ]
Gillesby, Brad [5 ]
Robson, Ewan J. D. [5 ]
机构：
[1] Juravinski Canc Ctr, Hamilton, ON, Canada
[2] British Columbia Canc Agcy, Vancouver, BC, Canada
[3] Moncton Hosp, Moncton, NB, Canada
[4] William Osler Hlth Syst, Brampton, ON, Canada
[5] Amgen Canada Inc, Mississauga, ON, Canada
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3038.3038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3038
引用
收藏
页数：6
相关论文
共 50 条
  • [41] A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma
    Cohen, Jonathon B.
    Switchenko, Jeffrey M.
    Koff, Jean L.
    Sinha, Rajni
    Kaufman, Jonathan L.
    Khoury, H. Jean
    Bumpers, Nassoma
    Colbert, Amanda
    Hutchison-Rzepka, Amanda
    Nastoupil, Loretta J.
    Heffner, Leonard T.
    Langston, Amelia A.
    Lechowicz, Mary Jo
    Lonial, Sagar
    Flowers, Christopher R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 539 - 546
  • [42] Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma
    Visani, G
    Guiducci, B
    D'Adamo, F
    Mele, A
    Nicolini, G
    Leopardi, G
    Sparaventi, G
    Barulli, S
    Malerba, L
    Isidori, A
    Malagola, M
    Piccaluga, PP
    LEUKEMIA & LYMPHOMA, 2005, 46 (03) : 477 - 479
  • [43] A Phase II Trial of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients with Previously Untreated Indolent Non-Hodgkin's Lymphoma
    Cohen, Jonathon B.
    Switchenko, Jeffrey
    Koff, Jean L.
    Sinha, Rajni
    Kaufman, Jonathan L.
    Khoury, H. Jean
    Bumpers, Nassoma K.
    Colbert, Amanda
    Hutchison-Rzepka, Amanda A.
    Nastoupil, Loretta J.
    Heffner, Leonard T.
    Langston, Amelia
    Lechowicz, Mary Jo
    Lonial, Sagar
    Flowers, Christopher R.
    BLOOD, 2014, 124 (21)
  • [44] Effects of the chemotherapeutic agents for non-hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), on the male rat reproductive system and progeny outcome
    Vaisheva, Farida
    Delbes, Geraldine
    Hales, Barbara F.
    Robaire, Bernard
    JOURNAL OF ANDROLOGY, 2007, 28 (04): : 578 - 587
  • [45] A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma.
    Tulpule, A
    Duran, CA
    Smith, DL
    Berman, NE
    Buchanan, L
    Gorospe, G
    Boswell, W
    Nathwani, B
    Levine, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 593S - 593S
  • [46] Cost benefit analysis of prophylactic granulocyte colony stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma
    Dranitsaris, G
    Altmayer, C
    Quirt, I
    PHARMACOECONOMICS, 1997, 11 (06) : 566 - 577
  • [47] Increased dose intensity (DI) of doxorubicin and vinblastine during ABVD therapy of Hodgkin's lymphoma with the use of granulocyte colony stimulating factor (GCSF).
    Raybon, K
    Schroeder, M
    Allerton, J
    BLOOD, 1995, 86 (10) : 3270 - 3270
  • [48] Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: A randomized study of the French Society of Pediatric Oncology
    Patte, C
    Laplanche, A
    Bertozzi, AI
    Baruchel, A
    Frappaz, D
    Schmitt, C
    Mechinaud, F
    Nelken, B
    Boutard, P
    Michon, J
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 441 - 448
  • [49] Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma
    Hanaoka, Kohei
    Hosono, Makoto
    Usami, Kimio
    Tatsumi, Yoichi
    Yamazoe, Yuzuru
    Komeya, Yoshihiro
    Tsuchiya, Norio
    Ishii, Kazunari
    Sumita, Mitsugu
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (08) : 678 - 683
  • [50] Randomized trial of granulocyte-colony stimulating factor (G-CSF) added to CHOP in elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
    Doorduijn, JK
    van der Holt, B
    van der Hem, KG
    van Imhoff, GW
    Kramer, MHH
    van Oers, MHJ
    Ossenkoppele, GJ
    Schaafsma, MR
    Verdonck, LF
    Verhoef, GEG
    Steijaert, MMC
    Lowenberg, B
    Sonneveld, P
    BLOOD, 2000, 96 (11) : 133A - 133A
12345